MAY 03, 2020

The Life Sciences Law Review – Edition 8: Chapter 2 Argentina



The pharmaceutical industry continues to be a highly regulated sector that has a very important presence in Argentina. Its financial results are highly affected by the influence of agreements entered into with social security organizations – mainly the social security organization that covers retired people – and private health insurance companies. These organizations agree on coverage that favours their affiliates with regard to prices from laboratories, wholesalers, and pharmacies. Despite the fact that these kinds of agreements continue to be in place, at least until March 2020, there have been changes in the financial politics these organizations have, owing to the fact that they are now calling for bids and joint purchases of certain products – mainly those related to oncologic and special treatment prognosis, which are usually the most expensive products.

Palabras clave: Derecho de la Salud · Life Sciences

Reproducido con el permiso de Law Business Research Ltd. Este artículo se publicó primero en abril 2020. Para más información, por favor contactar a 

The Life Sciences Law Review - Edition 8: Chapter 2 Argentina
Ver en el sitio de The Law Reviews